Table 2.
Variable Group | PARP-1+/+, C | PARP-1+/+, D | PARP-1−/−, C | PARP-1−/−, D |
---|---|---|---|---|
Water intake (ml) | 4.6 ± 1.5 | 28.5 ± 5.2** | 6.1 ± 1.7 | 16.3 ± 6.0**, ## |
Urination volume (ml) | 0.53 ± 0.14 | 20.8 ± 4.4** | 1.26 ± 0.40 | 10.7 ± 3.2**, ## |
Albuminuria (μg 48 h−1) | 14.8 ± 4.2 | 314 ± 45** | 15.5 ± 6.9 | 200 ± 53**, # |
Proteinuria (mg 48 h−1) | 22.0 ± 5.0 | 317 ± 41** | 28.5 ± 7.1 | 203 ± 51**,# |
Creatinine excretion (mg/48 h−1) | 255 ± 44 | 3,187 ± 473** | 287 ± 38 | 3,517 ± 570** |
UA/CR (μg/mg) | 0.09 ± 0.01 | 0.16 ± 0.02** | 0.09 ± 0.01 | 0.12 ± 0.01**,# |
UP/CR (mg/mg) | 0.05 ± 0.01 | 0.15 ± 0.02** | 0.08 ± 0.01 | 0.11 ± 0.01**,# |
Data are expressed as Means ± SEM. n = 7–15 per group. C – control mice; D – diabetic mice; PARP-1 poly(ADP-ribose) polymerase-1; UA/CR – urinary albumin-to-creatinine ratio; UP/CR – urinary protein-to-creatinine ratio.
p < 0.01 vs corresponding non-diabetic groups;
p < 0.05 and < 0.01 vs diabetic wild-type mice.